Qyuns Therapeutics Co., Ltd.

HK$14.33As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2509Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR (17.35%)
Div yield —
ROE 101.58%
Biotechnology
Beta (5Y) 1.46
PE TTM 5.112
TSR TTM (34.21%)
Mkt cap HK$3.201B
ROIC 30.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
(0.59%)
(54.95%)
Hold 12|12|4|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.39
0.40
0.43
30.13%
24.56%
12.53%
14.67%
Revenue¥M
269.2
280.6
297.0
312.1
7.03%
6.77%
14.90%
20.42%
Peers (US$408.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.760
(0.301)
(0.233)
EBIT/Intx
1.335
2.900
2.022
Own earn%
19.28
(46.16)
(47.45)
Sh yield%
24.26
35.44
32.31
Owners
Insiders/Inst%
8.38
32.61
Short interest%
5.74
SBC / revenue%
1.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
5–10
$1 testx
0.0
Incr. ROIC%
12